Dr. Kudchadkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd Ne
2nd Floor
Atlanta, GA 30322Phone+1 813-745-8581
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2006 - 2009
Emory University School of MedicineResidency, Internal Medicine, 2003 - 2006- Emory University School of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2013 - 2023
FL State Medical License 2009 - 2015
CO State Medical License 2006 - 2011- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer Start of enrollment: 2017 Jan 27
- Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer Start of enrollment: 2020 May 15
Publications & Presentations
PubMed
- 194 citationsSafety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic MelanomaGeoffrey T. Gibney, Ragini R. Kudchadkar, Ronald C. DeConti, Melissa S. Thebeau, Maria P. Czupryn
Clinical Cancer Research. 2015-02-15 - 59 citationsMetastatic melanoma.Ragini R Kudchadkar, Michael C Lowe, Mohammad K Khan, Stephanie M McBrien
CA. 2020-03-01 - 48 citationsCombined BRAF and HSP90 inhibition in patients with unresectable BRAF V600E mutant melanomaZeynep Eroglu, Y. Ann Chen, Geoffrey T. Gibney, Jeffrey S. Weber, Ragini R. Kudchadkar
Clinical Cancer Research. 2018-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
